Literature DB >> 19595848

Lowering the risk of Alzheimer's disease: evidence-based practices emerge from new research.

M Kathryn Jedrziewski1, Virginia M-Y Lee, John Q Trojanowski.   

Abstract

BACKGROUND: The increasing prevalence of Alzheimer's disease (AD) and other aging-related dementias as the population ages will have a dramatic impact on both provision of health care and the economy if nothing is done to prevent or delay the onset of AD or to slow its progression.
METHODS: A comprehensive review of the literature in several promising areas of inquiry, other than those representing Food and Drug Administration (FDA)-approved AD- or dementia-specific pharmacologic therapies, that may impact the risk or progression of AD and related dementias was undertaken.
RESULTS: Results highlight a number of factors associated with AD and dementia. These include education and occupation, cognitive and leisure activities, exercise, cholesterol and statins, and head trauma.
CONCLUSIONS: Factors associated with AD and dementia may have potential as strategies useful in preventing or delaying AD and dementia or slowing its progression. Further research is needed to determine the validity and strength of the associations and to ascertain causality.

Entities:  

Year:  2005        PMID: 19595848     DOI: 10.1016/j.jalz.2005.09.007

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  9 in total

1.  Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2001.

Authors:  Kathleen S Hall; Sujuan Gao; Olusegun Baiyewu; Kathleen A Lane; Oye Gureje; Jianzhao Shen; Adesola Ogunniyi; Jill R Murrell; Frederick W Unverzagt; Jeanne Dickens; Valerie Smith-Gamble; Hugh C Hendrie
Journal:  Alzheimers Dement       Date:  2009-05       Impact factor: 21.566

2.  Physical activity and cognitive health.

Authors:  M Kathryn Jedrziewski; Virginia M-Y Lee; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2007-04       Impact factor: 21.566

3.  Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States.

Authors:  Walter A Rocca; Ronald C Petersen; David S Knopman; Liesi E Hebert; Denis A Evans; Kathleen S Hall; Sujuan Gao; Frederick W Unverzagt; Kenneth M Langa; Eric B Larson; Lon R White
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

Review 4.  Current and future uses of neuroimaging for cognitively impaired patients.

Authors:  Gary W Small; Susan Y Bookheimer; Paul M Thompson; Greg M Cole; S-C Huang; Vladimir Kepe; Jorge R Barrio
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

Review 5.  Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature.

Authors:  Christianna Purnell; Sujuan Gao; Christopher M Callahan; Hugh C Hendrie
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

6.  Healthy brain aging: a meeting report from the Sylvan M. Cohen Annual Retreat of the University of Pennsylvania Institute on Aging.

Authors:  Lisa J Bain; Kathy Jedrziewski; Marcelle Morrison-Bogorad; Marilyn Albert; Carl Cotman; Hugh Hendrie; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2008-10-22       Impact factor: 21.566

7.  Long-term anticholinergic use and the aging brain.

Authors:  Xueya Cai; Noll Campbell; Babar Khan; Christopher Callahan; Malaz Boustani
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

8.  Older primary care patients' attitudes and willingness to screen for dementia.

Authors:  Nicole R Fowler; Anthony J Perkins; Hilary A Turchan; Amie Frame; Patrick Monahan; Sujuan Gao; Malaz A Boustani
Journal:  J Aging Res       Date:  2015-04-20

9.  Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study.

Authors:  Simon Forstmeier; Andreas Maercker
Journal:  BMC Psychiatry       Date:  2015-11-17       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.